The Safety of Using Buprenorphine With Naloxone in a Buccal Film to Initiate Treatment of Opioid Dependent Subjects
Status:
Withdrawn
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
A randomized, double blind, active controlled study in approximately 40 opioid dependent
subjects. Study duration is up to five days and includes a maximum of 3 days confinement in
the clinic. Opioid dependent subjects who provide informed consent meet all entry criteria
are eligible for enrollment into the study.